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Summary  Hepatitis  C  virus  can  be  detected  in  blood  and  other  bodily  ﬂuids,  such
as  saliva.  The  aim  of  this  study  was  to  detect  and  quantify  the  HCV-RNA  in  saliva  and
plasma  from  patients  with  chronic  hepatitis  C  infections,  as  well  as  check  the  levelqPCR;
Viral  subtype;
Ethnicity
of  viral  load  in  sex  groups  (age,  ethnicity  and  virus  subtypes).  Whole  saliva  and  blood
from  70  patients  with  chronic  hepatitis  C  infections  attended  at  the  department  of
gastroenterology  from  University  Hospital.  The  HCV-RNA  load  was  performed  by  qRT-
PCR  using  Sybr  Green  I  master  mix.  HCV-RNA  was  detected  in  80%  (56/70)  of  patients
in  saliva  and  92.85%  (65/70)  in  plasma.  The  median  of  the  viral  load  in  the  plasma
was  of  4.87  log10,  and  in  saliva,  it  was  3.32  log10, (p  =  0.0005).  Female  patients  and
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black  patients  exhibited  a negative  correlation  between  the  HCV-RNA  load  in  saliva
vs.  the  HCV-RNA  load  in  plasma  (r  =  −0.3172,  CI95% −0.6240  to  −0.03736,  p  =  0.0491)
and  (r  =  −0.3141;  IC95% −0.6069  to  −0.05926;  p  =  0.0209),  respectively.  HCV-RNA  was
detected  and  quantiﬁed  in  saliva  samples,  and  according  to  the  quantiﬁcation  levels,
saliva  may  be  a  possible  transmission  source  of  HCV,  particularly  in  women  and  people
of  black  ethnicity  who  develop  chronic  HCV  infections.
©  2015  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
ed.
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a sterile  falcon  tube  (capacity  50  mL).  After  the
saliva collection,  1  mL  of  saliva  was  separated  forLimited.  All  rights  reserv
ntroduction
epatitis  C  is  a  public  health  problem  with  approx-
mately 170  million  people  chronically  infected
1—3].  Approximately  80%  of  patients  infected  with
he hepatitis  C  virus  (HCV)  develop  chronic  infec-
ions that  could  lead  to  cirrhosis  and  hepatocellular
arcinoma [4]  because  HCV  plays  an  important  role
ot only  in  diseases  of  the  liver  but  in  a  variety
f extrahepatic  manifestations  and  immune  abnor-
alities  [2].
While  the  detection  of  HCV  antibodies  in  serum
s a  traditional  diagnostic  method,  the  use  of  saliva
amples  for  the  diagnosis  of  HCV  infection  offers
 number  of  potential  advantages,  such  as  minimal
nvasiveness  and  skill  necessary  to  collect  a  sample.
hese  samples  are  especially  suitable  for  preva-
ence studies  when  blood  samples  are  difﬁcult  to
btain, as  in  injecting  drug  users,  hemophiliacs  and
hildren. Furthermore,  the  analysis  of  saliva  may
rovide  a  better  cost-beneﬁt  for  screening  in  large
opulations  [5,6].
Many  studies  have  documented  the  suitabil-
ty of  saliva  samples  for  the  diagnosis  of  the
CV infection  using  enzyme  immunoassays  and
olymerase  chain  reaction  in  real-time  (RT-qPCR)
1,5,7—10].  These  studies  have  shown  differences
n methodology;  a  number  tested  whole  saliva  for
CV, while  others  tested  centrifuged  supernatant
11].
Regarding  the  detection,  the  analysis  of  viral
oad, the  best  methodology,  the  barriers  to
ransmission of  HCV  in  saliva,  and  the  possible
echanisms and  infectious  ability  of  a  biological
uid, there  are  still  no  conclusive  answers  among
esearchers. The  aim  of  this  study  was  to  detect
CV-RNA and  quantify  the  viral  load  in  saliva  and  in
lasma from  patients  with  chronic  hepatitis  C  infec-
ions not  receiving  any  antiviral  treatment  and  to
haracterize  and  to  analyze  the  viral  loads  accord-
ng to  demographics  (gender,  age,  ethnicity  and
t
s
t
wirus  subtypes);  depending  on  the  viral  load  level,
aliva may  be  a possible  route  of  HCV  transmission
or certain  risk  groups.
aterials and methods
thical aspects
his  research  was  approved  by  the  Ethics  Com-
ittee of  Research  (Centro  de  Ciências  da
aúde/UFPE), CAAE:  10148913.7.0000.5208.  All
atients completed  an  informed  consent  document
bout the  research.
atients and samples
e  studied  70  patients  with  chronic  hepatitis  C
nfections  and  positive  HCV  serum  antibody  tests,
ho had  not  started  treatment  with  antiviral  drugs,
een in  the  gastroenterology  outpatient  facility
f the  Clinical  Hospital  of  the  Federal  Univer-
ity of  Pernambuco  from  April  2013  to  September
013.
Blood collection: 4  mL  of  peripheral  blood  were
ollected  in  tubes  containing  EDTA  anticoagulant,
hich was  centrifuged  (1500  rpm/15  min)  and  sep-
rated in  plasma  and  cells.  Two  hundred  L  of
uanidine isothiocyanate  solution  was  added  to
 mL  of  plasma  (4  M)  and  stored  at  −80 ◦C.
The patient  chewed  a piece  of  sterile  soft  rub-
er (diameter  of  0.5  cm  and  length  of  1.0  cm),  then
 mL  of  saliva  were  collected,  which  was  put  intohe addition  of  200  L  of  guanidine  isothiocyanate
olution (4  M)  and  stored  at  −80 ◦C.  The  maximum
ime between  the  collection  and  storage  of  samples
as 2  h.
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Figure  1  Viral  load  from  HCV-RNA  patients  in  plasma,
median  by  the  Mann—Whitney  test.
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For  the  HCV-RNA  extraction  (saliva  and  plasma),
400 L  of  sample  was  used,  according  to  the  method
based  on  phenol  acid  (pH  ±  5.0)/chloroform
according  to  Sambrook  and  Russell  [12]. The
sample was  resuspended  in  20  L  of  water  with
diethylpyrocarbonate-DEPC  (0.1%)  and  stored
at −80 ◦C.  The  cDNA  was  constructed  using
random primers  and  the  IMPROM-IITM Reverse
Transcription  System  kit  (Promega®;  Fitchburg,
Wisconsin, USA,  2013).  Subsequently,  the  RNA  was
quantiﬁed  using  Nanodrop  2000  (Thermo  Fisher
Scientiﬁc,  Wilmington,  USA,  2012),  with  an  average
concentration  of  800  g/L.
RT-qPCR reaction
Approximately  2  L  of  cDNA  was  used  for  a mix
containing: 1×  Sybr  Green  I  (Promega®;  Fitchburg,
Wisconsin, USA,  2013)  and  0.5  pmol/L  of  primers
940 (5′-TTC  ACG  CAG  AAA  GCG  TCT  AG-3′)  and  211
(5′-CAC  TCT  CGA  GCA  CCC  TAT  CAG  GCA  GT-3′)
(adapted of  Chang  et  al.)  [13]. The  cycling  con-
ditions  were  as  follows:  1◦ heating  50 ◦C/2  min;
2◦ heating  95 ◦C/12  min/45  times  (95 ◦C/20  s;
50 ◦C/60  s;  72 ◦C/35  s).  Then,  the  mixture  was  grad-
ually heated  (60—95 ◦C,  with  increases  of  0.7 ◦C
per 7  s).  The  melting  (78  ±  1.5 ◦C)  was  analyzed
to verify  the  speciﬁcity  of  the  amplicons.  For  the
quantiﬁcation  of  HCV-RNA,  a  standard  curve  ranging
from 101 to  109 copies/mL  was  used  from  positive
HCV-RNA control  samples,  conﬁrmed  in  a  reference
laboratory from  state  of  Pernambuco.  The  results
were analyzed  in  copies/mL  and  log10.
Statistical analysis
The  GraphPad  Prism  5.0  software  was  used  for
the association  of  viral  load  according  to  two  con-
tinuous  variables  (the  Mann—Whitney  test).  We
used the  Pearson  correlation  test  for  to  measure
the degree  of  linear  relation  (positive  or  negative)
between two  continuous  variables.  All  results  with
p values  <0.05  were  indicative  of  statistical  signiﬁ-
cance.
Results
HCV-RNA  was  detected  in  80%  (56/70)  of  saliva  sam-
ples and  92.85%  (65/70)  of  plasma  samples.The viral  load  in  plasma  was  higher
(75,699  copies/mL  or  4.879  log10; CI95% 4.29
to 5.46),  than  in  saliva  (2118  copies/mL  or  3.32
log10;  CI95% 2.58—4.05)  (p  = 0.0005,  Fig.  1).
i
e
c
fOnly  three  patients  showed  HCV-RNA  quantiﬁca-
ion in  saliva  (5,293,423  copies/mL  or  6.724  log10)
nd an  absence  of  plasma  viral  load.
Of  the  patients,  39  (55.71%)  were  women,  and
1 (44.28%)  were  men,  presenting  a  range  age  of
6—77 years  (mean  of  55  years).
The genotype  1b  was  most  frequent  in  the  HCV
atients  (32/70).  The  genotype  3a  (5/70)  was  found
nly in  female  patients,  and  the  median  viral  load
as higher  in  plasma  (6.88  log10).
Genotype 1b  (32/70)  and  genotype  1a  (5/70)  also
howed  high  viral  loads  in  the  plasma,  with  medians
f 5.14  log10 and  5.30  log10,  respectively.
Comparing  the  viral  load  in  plasma  vs.  saliva,
here was  a negative  correlation;  four  female
atients (r2 =  10%  of  female  patients)  who  pre-
ented an  increased  viral  load  in  the  plasma
lso showed  a decreased  viral  load  in  the
aliva (r  = −0.3172,  CI95% −0.6240  to  −0.03736,
 =  0.0491,  Fig.  2a).  Male  patients  showed  no  sta-
istically signiﬁcant  correlation  (r  = −0.0739,  CI95%
0.2794  to  0.1896,  p =  0.6926,  Fig.  2b).
There was  no  difference  in  the  viral  load
etween men  and  women,  according  to  age,
ace, and  virus  subtype  (Table  1).  However,  in
elation black  ethnicity,  there  was  a  negative  cor-
elation (r  =  −0.3141;  IC95% −0.6069  to  −0.05926;
 =  0.0209),  as  13.2%  (r2) of  black  patients  had  a
igh viral  load  in  the  saliva,  and  simultaneously,  a
ow viral  load  in  the  plasma  (Fig.  3).
iscussion
t  is  estimated  that  3%  of  the  world  population  are
nfected  with  HCV  and  at  risk  of  developing  dis-
ase complications.  According  to  WHO,  Brazil  is
onsidered a country  of  intermediate  endemicity
or hepatitis  C,  ranging  from  1%  to  2%  [4].
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Figure  2  Correlation  of  viral  load  levels  in  the  plasma  vs.  viral  load  in  the  saliva  in  female  patients,  n  =  39  (a)  and
viral  load  in  saliva,  male  patients,  n  =  31  (b),  by  the  Pearson  correlation  test.
Detection  of  HCV-RNA  by  real-time  qPCR  was
investigated in  a  greater  sample  size  in  this  study
than in  others  [2,10,11,14—17].  The  detection  fre-
quency of  HCV-RNA  in  serum  was  92.85%  of  the
positive samples  compared  with  82%  in  another
study [15].  The  percentages  presented  by  other
authors  are  as  follows:  20.5%,  31%,  42.5%,  52.4%,
52.4%,  62%,  and  72%  [2,10,11,14—17].
The results  of  this  research  showed  a  higher  viral
load in  plasma  (median  4.879  log10)  than  in  saliva
samples (median  3.32  log10).  The  results  were  sim-
ilar to  a  study  by  Menezes  et  al.  [6]  with  HCV-RNA
levels of  5.78  log10 copies  in  serum  and  3.32  log10
copies  in  saliva.
Three studies,  in  particular,  showed  that  the
HCV-RNA load  in  serum  is  higher  than  in  saliva
from patients  with  chronic  hepatitis  C  infections.  In
the ﬁrst  study,  the  mean  was  2.52  × 107 copies/mL
in serum  and  1.15  ×  106 copies/mL  in  saliva  [18].
In the  second,  the  mean  HCV-RNA  in  serum  was
Figure  3  Correlation  of  HCV  load  levels  in  the  plasma
vs.  HCV  load  in  the  saliva  in  black  patients  (n  =  40),  by
the  Pearson  correlation  test.
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[.1  ×  105 copies/mL  and  1.9  ×  104 copies/mL  in  the
aliva [16]. In  the  third  study,  the  viral  load  ranged
rom  1.1  ×  104 to  1.9  ×  106 IU/mL  in  the  plasma
nd 1.1  ×  103 to  1.3  ×  105 IU/mL  in  the  saliva  [2].
hese results  were  similar  to  ours;  the  plasma  viral
oad was  higher  (75,699  copies/mL)  than  the  saliva
oad.
There was  a  negative  correlation  between  viral
oad in  plasma  and  viral  load  in  saliva  in  female
atients (r =  −0.3172,  p  =  0.0491),  whereas  in  male
atients  there  was  no  signiﬁcant  correlation.  Our
esults conﬂict  with  some  studies  that  claim  to  have
ound no  statistical  correlation  between  the  pres-
nce of  HCV-RNA  in  the  saliva  and  gender  [2,14,15].
ermida et  al.  [14]  found  a statistically  signiﬁcant
ositive correlation  between  the  HCV-RNA  load  in
lasma and  HCV-RNA  detection  in  the  saliva.  Wang
t al.  [10]  reported  that  HCV-RNA  is  frequently
ound in  saliva  from  patients  with  high  serum  HCV-
NA loads.
HCV is  classiﬁed  in  six  major  genotypes  (des-
gnated of  1—6),  and  several  dozen  subtypes  and
trains  based  on  the  heterogeneity  of  the  genomic
equence.  Genotypes  1,  2,  and  3 are  distributed
orldwide; among  them,  genotypes  1a  and  1b  are
ore prevalent,  representing  60%  of  the  infec-
ion genotypes  [19].  As  described  in  other  studies
6,15,19,20],  genotype  1b  was  present  in  64%  of  our
ases (32/50  of  patients  with  genotype  1).
However, epidemiological  studies  suggest  that
he infectivity  of  HCV  in  the  saliva  is  low,  but  it  was
ot possible  to  determine  the  infectious  potential.
urthermore, HCV-speciﬁc  receptors  have  been
eﬁned  in  buccal  epithelial  cell  pellets,  and  the  role
f host  defense  mechanisms  has  been  determined
21].
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Several  hypotheses  are  evaluated  in  scientiﬁc
ircles; blood  mononuclear  cells  infected  with  HCV
ay allow  the  virus  to  inﬁltrate  the  crevicular  and
aliva ﬂuids  [22]. In  recent  research,  the  authors
oncluded  that  CD3+ cells  are  the  dominant  site
or extrahepatic  replication  of  HCV,  although  other
ubpopulations  of  peripheral  blood  can  also  sup-
ort virus  replication  [23]. Saliva  containing  HCV
an penetrate  the  gingival  sulcus  [24]; however,
aliva may  not  be  the  only  route  for  HCV-RNA
o gain  systemic  access  in  edentulous  patients
25]. There  may  be  transudation  of  serum  con-
aining HCV  into  the  mouth.  There  is  also  the
ossibility that  HCV  exists  within  the  mucosal
pithelial cell  pellet  because  HCV  has  been  iden-
iﬁed in  the  mucosal  tissue  and  salivary  glands
6,16,20]. This  mechanism  would  explain  the  detec-
ion of  different  viral  genotypes  in  the  serum
nd saliva  of  the  same  patient  [25]  and  patients
ho are  HCV-RNA  seronegative  but  saliva-positive
26].
The  use  of  viral  RNA  quantiﬁcation  as  an  evo-
utionary determinant  or  a  predictor  of  hepatitis
 disease  severity  is  of  relative  value.  The  cor-
ect interpretation  of  viral  load  should  be  made
onsidering  multiple  factors,  more  complex  than
he simple  value  obtained  in  the  quantiﬁcation
27].
Wang  et  al.  [10]  demonstrated  that  the  lev-
ls of  serum  and  saliva  viral  loads  in  HCV-RNA
atients change  during  the  course  of  infection.  In
he study  by  Gonc¸alves  et  al.  [15],  all  patients  with
etectable  HCV-RNA  in  saliva  samples  were  also
ositive for  HCV-RNA  in  the  plasma.  However,  some
uthors reported  that  they  were  able  to  detect  HCV
n the  saliva,  but  failed  to  detect  it  in  the  blood,
s occurred  in  5  patients  in  the  studied  samples
25,28—30].
We  observed  a higher  viral  load  in  plasma  than
n saliva.  Some  patients  presented  a  high  viral  load
n the  saliva  and  low  viral  load  in  the  serum,  sug-
esting  a  possible  transmission  route  of  the  HCV.
his information  is  a relevant  knowledge  to  health
rofessionals,  such  as  dentists  with  a  high  expo-
ure risk.  This  study  has  useful  biological  material
or use  in  epidemiological  studies;  however,  further
ohort studies  are  warranted  to  monitor  the  plasma
rom patients  showing  variable  viral  load  and  iden-
ify receptors  that  favor  the  presence  of  HCV  in  the
ral mucosa.unding
o  funding  sources.
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